We are analyzing https://link.springer.com/article/10.1007/s10549-010-1023-8.

Title:
Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer | Breast Cancer Research and Treatment
Description:
Exposure to higher levels of estrogen produces genotoxic metabolites that can stimulate mammary tumorigenesis. Induction of NF-E2-related factor 2 (NRF2)-dependent detoxifying enzymes (e.g., NAD(P)H-quinone oxidoreductase 1 (NQO1)) is considered an important mechanism of protection against estrogen-associated carcinogenesis because they would facilitate removal of toxic estrogens. Here, we studied the impact of estrogen-receptor (ER) signaling on NRF2-dependent gene transcription. In luciferase assay experiments using the 5-flanking region of the human NQO1 gene promoter, we observe that ERα ligand-binding domain (LBD) is required for estrogen inhibition of NQO1 promoter activity in estrogen-dependent breast cancer cells. Chromatin immunoprecipitation (ChIP) assay shows that estrogen recruits ERα and a class III histone deacetylase SIRT1 at the NQO1 promoter, leading to inhibition of NQO1 transcription. Inhibition of ERα expression by the antiestrogen shikonin reverses the inhibitory effect of estrogen on NQO1 expression. As a consequence, a chemoprevention study was undertaken to monitor the impact of shikonin on DNA lesions and tumor growth. Treatment of MCF-7 breast cancer cells with shikonin inhibits estrogen-induced 8-hydroxy-2-deoxyguanosine (8-OHdG), a marker of DNA damage. NQO1 deficiency promotes estrogen-dependent tumor formation, and shikonin inhibits estrogen-dependent tumor growth in an NQO1-dependent manner in MCF-7 xenografts. These results suggest that estrogen-receptor signaling pathway has an inhibitory effect on NRF2-dependent enzymes. Moreover, shikonin reverses the inhibitory effects of estrogen on this pathway and may contribute to breast cancer prevention.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,016 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

article, google, scholar, pubmed, cas, cancer, estrogen, breast, nqo, inhibition, shikonin, usa, receptor, zhou, biol, tamoxifen, research, signaling, nrf, davidson, privacy, cookies, pathway, yao, brodie, kensler, carcinogenesis, gene, transcription, human, chemoprevention, dna, damage, natl, mol, content, publish, search, induction, activity, estrogendependent, expression, study, tumor, mcf, access, rogan, steroid, alpha, chem,

Topics {✒️}

antiestrogen-liganded estrogen receptor-alpha nrf2-dependent gene transcription month download article/chapter antagonist-occupied steroid receptors small-cell lung cancer nf-e2-related factor 2 erα ligand-binding domain dysfunctional keap1-nrf2 interaction estrogen-receptor signaling pathway full article pdf ligand-dependent interaction estrogen receptor alpha deoxyribonucleic acid binding privacy choices/manage cookies estrogen-induced mammary antiestrogen shikonin reverses nqo1-dependent manner estrogen receptor-beta dependent detoxifying enzymes article yao nrf2-dependent enzymes endogenous tumor initiators estrogen signaling activates kensler tw estrogen recruits erα montano mm h-quinone oxidoreductase 1 cell survival responses nqo1 promoter activity european economic area stimulate mammary tumorigenesis cavalieri el van breemen rb erbeta coactivator complex protein phosphatase 2a coactivators pgc-1beta src-1 interact functionally aromatase inhibitor letrozole mcf-7 tumors implanted tumoristatic action genotoxic mutagenic carcinogen graham jd nih p50 ca088843 conditions privacy policy estradiol-stimulated growth cancer protective genes pittsburgh cancer institute nqo1 transcription luciferase assay experiments mediate transcriptional upregulation

Questions {❓}

Kensler TW, Wakabayashi N (2010) Nrf2: friend or foe for chemoprevention?
Liehr JG (2000) Is estradiol a genotoxic mutagenic carcinogen?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer
         description:Exposure to higher levels of estrogen produces genotoxic metabolites that can stimulate mammary tumorigenesis. Induction of NF-E2-related factor 2 (NRF2)-dependent detoxifying enzymes (e.g., NAD(P)H-quinone oxidoreductase 1 (NQO1)) is considered an important mechanism of protection against estrogen-associated carcinogenesis because they would facilitate removal of toxic estrogens. Here, we studied the impact of estrogen-receptor (ER) signaling on NRF2-dependent gene transcription. In luciferase assay experiments using the 5-flanking region of the human NQO1 gene promoter, we observe that ERα ligand-binding domain (LBD) is required for estrogen inhibition of NQO1 promoter activity in estrogen-dependent breast cancer cells. Chromatin immunoprecipitation (ChIP) assay shows that estrogen recruits ERα and a class III histone deacetylase SIRT1 at the NQO1 promoter, leading to inhibition of NQO1 transcription. Inhibition of ERα expression by the antiestrogen shikonin reverses the inhibitory effect of estrogen on NQO1 expression. As a consequence, a chemoprevention study was undertaken to monitor the impact of shikonin on DNA lesions and tumor growth. Treatment of MCF-7 breast cancer cells with shikonin inhibits estrogen-induced 8-hydroxy-2-deoxyguanosine (8-OHdG), a marker of DNA damage. NQO1 deficiency promotes estrogen-dependent tumor formation, and shikonin inhibits estrogen-dependent tumor growth in an NQO1-dependent manner in MCF-7 xenografts. These results suggest that estrogen-receptor signaling pathway has an inhibitory effect on NRF2-dependent enzymes. Moreover, shikonin reverses the inhibitory effects of estrogen on this pathway and may contribute to breast cancer prevention.
         datePublished:2010-07-10T00:00:00Z
         dateModified:2010-07-10T00:00:00Z
         pageStart:585
         pageEnd:591
         sameAs:https://doi.org/10.1007/s10549-010-1023-8
         keywords:
            Estrogen receptor
            NRF2
            NQO1
            Chemoprevention
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1023-8/MediaObjects/10549_2010_1023_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1023-8/MediaObjects/10549_2010_1023_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1023-8/MediaObjects/10549_2010_1023_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1023-8/MediaObjects/10549_2010_1023_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1023-8/MediaObjects/10549_2010_1023_Fig5_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:124
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yuan Yao
               affiliation:
                     name:University of Maryland School of Medicine
                     address:
                        name:Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Angela M. H. Brodie
               affiliation:
                     name:University of Maryland School of Medicine
                     address:
                        name:Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nancy E. Davidson
               affiliation:
                     name:University of Pittsburgh Cancer Institute
                     address:
                        name:University of Pittsburgh Cancer Institute, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Thomas W. Kensler
               affiliation:
                     name:University of Pittsburgh
                     address:
                        name:Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qun Zhou
               affiliation:
                     name:University of Maryland School of Medicine
                     address:
                        name:Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer
      description:Exposure to higher levels of estrogen produces genotoxic metabolites that can stimulate mammary tumorigenesis. Induction of NF-E2-related factor 2 (NRF2)-dependent detoxifying enzymes (e.g., NAD(P)H-quinone oxidoreductase 1 (NQO1)) is considered an important mechanism of protection against estrogen-associated carcinogenesis because they would facilitate removal of toxic estrogens. Here, we studied the impact of estrogen-receptor (ER) signaling on NRF2-dependent gene transcription. In luciferase assay experiments using the 5-flanking region of the human NQO1 gene promoter, we observe that ERα ligand-binding domain (LBD) is required for estrogen inhibition of NQO1 promoter activity in estrogen-dependent breast cancer cells. Chromatin immunoprecipitation (ChIP) assay shows that estrogen recruits ERα and a class III histone deacetylase SIRT1 at the NQO1 promoter, leading to inhibition of NQO1 transcription. Inhibition of ERα expression by the antiestrogen shikonin reverses the inhibitory effect of estrogen on NQO1 expression. As a consequence, a chemoprevention study was undertaken to monitor the impact of shikonin on DNA lesions and tumor growth. Treatment of MCF-7 breast cancer cells with shikonin inhibits estrogen-induced 8-hydroxy-2-deoxyguanosine (8-OHdG), a marker of DNA damage. NQO1 deficiency promotes estrogen-dependent tumor formation, and shikonin inhibits estrogen-dependent tumor growth in an NQO1-dependent manner in MCF-7 xenografts. These results suggest that estrogen-receptor signaling pathway has an inhibitory effect on NRF2-dependent enzymes. Moreover, shikonin reverses the inhibitory effects of estrogen on this pathway and may contribute to breast cancer prevention.
      datePublished:2010-07-10T00:00:00Z
      dateModified:2010-07-10T00:00:00Z
      pageStart:585
      pageEnd:591
      sameAs:https://doi.org/10.1007/s10549-010-1023-8
      keywords:
         Estrogen receptor
         NRF2
         NQO1
         Chemoprevention
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1023-8/MediaObjects/10549_2010_1023_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1023-8/MediaObjects/10549_2010_1023_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1023-8/MediaObjects/10549_2010_1023_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1023-8/MediaObjects/10549_2010_1023_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1023-8/MediaObjects/10549_2010_1023_Fig5_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:124
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yuan Yao
            affiliation:
                  name:University of Maryland School of Medicine
                  address:
                     name:Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Angela M. H. Brodie
            affiliation:
                  name:University of Maryland School of Medicine
                  address:
                     name:Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nancy E. Davidson
            affiliation:
                  name:University of Pittsburgh Cancer Institute
                  address:
                     name:University of Pittsburgh Cancer Institute, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Thomas W. Kensler
            affiliation:
                  name:University of Pittsburgh
                  address:
                     name:Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qun Zhou
            affiliation:
                  name:University of Maryland School of Medicine
                  address:
                     name:Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:124
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Maryland School of Medicine
      address:
         name:Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, USA
         type:PostalAddress
      name:University of Maryland School of Medicine
      address:
         name:Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, USA
         type:PostalAddress
      name:University of Pittsburgh Cancer Institute
      address:
         name:University of Pittsburgh Cancer Institute, Pittsburgh, USA
         type:PostalAddress
      name:University of Pittsburgh
      address:
         name:Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, USA
         type:PostalAddress
      name:University of Maryland School of Medicine
      address:
         name:Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yuan Yao
      affiliation:
            name:University of Maryland School of Medicine
            address:
               name:Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, USA
               type:PostalAddress
            type:Organization
      name:Angela M. H. Brodie
      affiliation:
            name:University of Maryland School of Medicine
            address:
               name:Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, USA
               type:PostalAddress
            type:Organization
      name:Nancy E. Davidson
      affiliation:
            name:University of Pittsburgh Cancer Institute
            address:
               name:University of Pittsburgh Cancer Institute, Pittsburgh, USA
               type:PostalAddress
            type:Organization
      name:Thomas W. Kensler
      affiliation:
            name:University of Pittsburgh
            address:
               name:Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, USA
               type:PostalAddress
            type:Organization
      name:Qun Zhou
      affiliation:
            name:University of Maryland School of Medicine
            address:
               name:Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, USA
      name:Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, USA
      name:University of Pittsburgh Cancer Institute, Pittsburgh, USA
      name:Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, USA
      name:Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(125)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.07s.

LINK . SPRINGER . COM {}